Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Louis Mayaud

Biographic Data

ID7961298
NAMELouis Mayaud
GIVEN NAMESLouis
FAMILY NAMEMayaud
SIGNATUREMAYAUD L
AFFILIATIONSMensia (France)
ORCID0000-0002-3187-8030
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD

    Open Access•Anna Kaiser, Anna K Kaiser et al.•ARTICLE•Frontiers in Psychiatry•2024

    Current findings indicate a potential value of self-report (BRIEF global score) and some objectively measured neurocognitive indices (CPT commission errors and hit reaction time variability) as treatment markers (of change) for MPH. However, we found a rather limited prognostic value with regard to predicting treatment response not (yet) allowing recommendation for clinical use. Baseline symptom severity was revealed as the most relevant predicto…

  • Personalized at‐home neurofeedback compared to long‐acting methylphenidate in children with ADHD

    Open Access•Diane Purper‐Ouakil, Hilario Blasco‐Fontecilla et al.•ARTICLE•Journal of Child Psychology and…•2022

    BACKGROUND: Neurofeedback is considered a promising intervention for the treatment of attention-deficit hyperactivity disorder (ADHD). NEWROFEED is a prospective, multicentre, randomized (3:2), reference drug-controlled trial in children with ADHD aged between 7 and 13 years. The main objective of NEWROFEED was to demonstrate the noninferiority of personalized at-home neurofeedback (NF) training versus methylphenidate in the treatment of children…

  • Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD

    Open Access•Aurore Bussalb, Marco Congedo et al.•ARTICLE•Frontiers in Psychiatry•2019

    Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one, thus making it difficult to determine a consensus of opinion on the effectiveness of NFB. This works brings continuity to the field by extending and …

No prominent works on this page.

  • Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD

    Open Access•Aurore Bussalb, Marco Congedo et al.•ARTICLE•Frontiers in Psychiatry•2019

    Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one, thus making it difficult to determine a consensus of opinion on the effectiveness of NFB. This works brings continuity to the field by extending and …

  • Personalized at‐home neurofeedback compared to long‐acting methylphenidate in children with ADHD

    Open Access•Diane Purper‐Ouakil, Hilario Blasco‐Fontecilla et al.•ARTICLE•Journal of Child Psychology and…•2022

    BACKGROUND: Neurofeedback is considered a promising intervention for the treatment of attention-deficit hyperactivity disorder (ADHD). NEWROFEED is a prospective, multicentre, randomized (3:2), reference drug-controlled trial in children with ADHD aged between 7 and 13 years. The main objective of NEWROFEED was to demonstrate the noninferiority of personalized at-home neurofeedback (NF) training versus methylphenidate in the treatment of children…

  • Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD

    Open Access•Anna Kaiser, Anna K Kaiser et al.•ARTICLE•Frontiers in Psychiatry•2024

    Current findings indicate a potential value of self-report (BRIEF global score) and some objectively measured neurocognitive indices (CPT commission errors and hit reaction time variability) as treatment markers (of change) for MPH. However, we found a rather limited prognostic value with regard to predicting treatment response not (yet) allowing recommendation for clinical use. Baseline symptom severity was revealed as the most relevant predicto…

Attention Deficit Hyperactivity Disorder (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Neural and Behavioral Psychology Studies (3 works) · Neurofeedback (3 works) · Psychiatry (3 works) · Psychology (3 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Electroencephalography (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae